David S. Newcombe

1.1k total citations
41 papers, 879 citations indexed

About

David S. Newcombe is a scholar working on Molecular Biology, Pharmacology and Nephrology. According to data from OpenAlex, David S. Newcombe has authored 41 papers receiving a total of 879 indexed citations (citations by other indexed papers that have themselves been cited), including 16 papers in Molecular Biology, 12 papers in Pharmacology and 9 papers in Nephrology. Recurrent topics in David S. Newcombe's work include Inflammatory mediators and NSAID effects (10 papers), Gout, Hyperuricemia, Uric Acid (9 papers) and Biochemical and Molecular Research (6 papers). David S. Newcombe is often cited by papers focused on Inflammatory mediators and NSAID effects (10 papers), Gout, Hyperuricemia, Uric Acid (9 papers) and Biochemical and Molecular Research (6 papers). David S. Newcombe collaborates with scholars based in United States. David S. Newcombe's co-authors include Carl P. Ciosek, Yoshinori Ishikawa, John V. Fahey, Joseph Chang, Ali M. Saboori, Alan S. Cohen, David M. Lang, Glenn A. Warr, Ahmed H. Esa and Michel Laviolette and has published in prestigious journals such as Nature, New England Journal of Medicine and Proceedings of the National Academy of Sciences.

In The Last Decade

David S. Newcombe

41 papers receiving 768 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
David S. Newcombe United States 20 287 191 113 93 88 41 879
A. Lupulescu United States 17 281 1.0× 216 1.1× 99 0.9× 57 0.6× 54 0.6× 69 962
Jonathan M. Gerrard United States 20 308 1.1× 320 1.7× 111 1.0× 125 1.3× 158 1.8× 41 1.4k
J Benvéniste France 21 310 1.1× 122 0.6× 86 0.8× 263 2.8× 171 1.9× 45 1.0k
R E Allen United Kingdom 7 241 0.8× 58 0.3× 81 0.7× 181 1.9× 107 1.2× 7 843
Ibert C. Wells United States 19 216 0.8× 55 0.3× 35 0.3× 54 0.6× 139 1.6× 42 1.0k
R. Müller‐Peddinghaus Germany 17 204 0.7× 151 0.8× 28 0.2× 172 1.8× 231 2.6× 63 877
Alan Broughton United States 18 231 0.8× 193 1.0× 74 0.7× 100 1.1× 38 0.4× 40 956
Stuart Levin United States 16 273 1.0× 96 0.5× 99 0.9× 151 1.6× 102 1.2× 41 913
P W Kohnen United States 15 209 0.7× 237 1.2× 77 0.7× 30 0.3× 96 1.1× 21 1.0k
Terumi Takahashi Japan 16 220 0.8× 57 0.3× 74 0.7× 126 1.4× 177 2.0× 43 783

Countries citing papers authored by David S. Newcombe

Since Specialization
Citations

This map shows the geographic impact of David S. Newcombe's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by David S. Newcombe with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites David S. Newcombe more than expected).

Fields of papers citing papers by David S. Newcombe

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by David S. Newcombe. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by David S. Newcombe. The network helps show where David S. Newcombe may publish in the future.

Co-authorship network of co-authors of David S. Newcombe

This figure shows the co-authorship network connecting the top 25 collaborators of David S. Newcombe. A scholar is included among the top collaborators of David S. Newcombe based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with David S. Newcombe. David S. Newcombe is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Newcombe, David S.. (1992). Immune surveillance, organophosphorus exposure, and lymphomagenesis. The Lancet. 339(8792). 539–541. 36 indexed citations
2.
Saboori, Ali M., David M. Lang, & David S. Newcombe. (1991). Structural requirements for the inhibition of human monocyte carboxylesterase by organophosphorus compounds. Chemico-Biological Interactions. 80(3). 327–338. 54 indexed citations
3.
Newcombe, David S., et al.. (1989). Successful management of Mycoplasma hominis septic arthritis involving a cementless prosthesis. The American Journal of Medicine. 87(3). 348–352. 20 indexed citations
4.
Newcombe, David S.. (1988). Leukotrienes: Regulation of Biosynthesis, Metabolism, and Bioactivity. The Journal of Clinical Pharmacology. 28(6). 530–549. 14 indexed citations
5.
Esa, Ahmed H., Glenn A. Warr, & David S. Newcombe. (1988). Immunotoxicity of organophosphorus compounds. Clinical Immunology and Immunopathology. 49(1). 41–52. 47 indexed citations
6.
Chang, Joseph, Mark C. Liu, & David S. Newcombe. (1982). Identification of two monohydroxyeicosatetraenoic acids synthesized by human pulmonary macrophages.. PubMed. 126(3). 457–9. 7 indexed citations
7.
Laviolette, Michel, Joseph Chang, & David S. Newcombe. (1981). Human alveolar macrophages: a lesion in arachidonic acid metabolism in cigarette smokers.. PubMed. 124(4). 397–401. 46 indexed citations
8.
Fahey, John V. & David S. Newcombe. (1978). The effect of 7-oxa-13 prostynoic acid on the mechanism of action of bradykinin in human synovial fibroblasts. Prostaglandins. 15(2). 333–342. 7 indexed citations
9.
Fahey, John V., Carl P. Ciosek, & David S. Newcombe. (1977). Human synovial fibroblasts: the relationships between cyclic AMP, bradykinin, and prostaglandins. Inflammation Research. 7(2). 255–264. 24 indexed citations
10.
Newcombe, David S.. (1975). Inherited biochemical disorders and uric acid metabolism. Medical Entomology and Zoology. 5 indexed citations
11.
Newcombe, David S., Carl P. Ciosek, Yoshinori Ishikawa, & John V. Fahey. (1975). Human synoviocytes: activation and desensitization by prostaglandins and 1-epinephrine.. Proceedings of the National Academy of Sciences. 72(8). 3124–3128. 59 indexed citations
12.
Newcombe, David S., et al.. (1974). Cyclic AMP and Thyroid Hormone: Inhibition of Epiphyseal Cartilage Cyclic 3',5'-Nucleotide Phosphodiesterase Activity by L-Triiodothyronine. Experimental Biology and Medicine. 147(3). 710–714. 6 indexed citations
13.
Newcombe, David S.. (1973). Gouty Arthritis and Polycystic Kidney Disease. Annals of Internal Medicine. 79(4). 605–605. 31 indexed citations
14.
Newcombe, David S., et al.. (1972). Activation of human synovial membrane adenylate cyclase by thyroid stimulating hormone (TSH). Biochemical and Biophysical Research Communications. 48(1). 201–204. 16 indexed citations
15.
Newcombe, David S.. (1972). Ethanol metabolism and uric acid. Metabolism. 21(12). 1193–1203. 17 indexed citations
16.
Donaldson, Milton H., et al.. (1970). URINARY AMINOIMIDAZOLECARBOXAMIDE LEVELS IN CHILDREN WITH ACUTE LEUKEMIA. PEDIATRICS. 45(6). 983–995. 10 indexed citations
17.
Newcombe, David S., et al.. (1969). Arthrogryposis multiplex congenita and spontaneous carpal fusion. Arthritis & Rheumatism. 12(4). 345–354. 3 indexed citations
18.
Dreifuss, Fritz E., et al.. (1968). X‐LINKED PRIMARY HYPERURICAEMIA (HYPOXANTHINE‐GUANINE PHOSPHORIBOSYLTRANSFERASE DEFICIENCY ENCEPHALOPATHY)*. Journal of Intellectual Disability Research. 12(2). 100–107. 4 indexed citations
19.
Sheppard, G L, et al.. (1966). X-Linked Recessive Inheritance of a Syndrome of Mental Retardation With Hyperuricemia. Experimental Biology and Medicine. 122(2). 609–611. 43 indexed citations
20.
Newcombe, David S. & Alan S. Cohen. (1965). Solubility characteristics of isolated amyloid fibrils. Biochimica et Biophysica Acta (BBA) - General Subjects. 104(2). 480–486. 20 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by A. Lupulescu Breakdown of academic impact, for papers by Jonathan M. Gerrard Breakdown of academic impact, for papers by J Benvéniste Breakdown of academic impact, for papers by R E Allen Breakdown of academic impact, for papers by Ibert C. Wells Breakdown of academic impact, for papers by R. Müller‐Peddinghaus Breakdown of academic impact, for papers by Alan Broughton Breakdown of academic impact, for papers by Stuart Levin Breakdown of academic impact, for papers by P W Kohnen Breakdown of academic impact, for papers by Terumi Takahashi
Rankless by CCL
2026